Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Alaunos Therapeutics, Inc. (TCRT) had Return on Investments of -41.35% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-1.16M |
|
-- |
|
-- |
|
$1.19M |
|
$-1.19M |
|
$0.03M |
|
$-1.16M |
|
$-1.16M |
|
$-1.16M |
|
$-1.16M |
|
$-1.16M |
|
$-1.16M |
|
$-1.19M |
|
$-1.19M |
|
2.18M |
|
2.18M |
|
$-5.50 |
|
$-5.50 |
|
| Balance Sheet Financials | |
$2.69M |
|
$0.10M |
|
$1.04M |
|
$3.72M |
|
$0.92M |
|
-- |
|
-- |
|
$0.92M |
|
$2.80M |
|
$2.80M |
|
$2.80M |
|
2.21M |
|
| Cash Flow Statement Financials | |
$-2.32M |
|
$-0.10M |
|
$3.26M |
|
$1.09M |
|
$1.94M |
|
$0.85M |
|
$0.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-41.35% |
|
-41.35% |
|
-31.12% |
|
|
Return on Investments |
-41.35% |
$1.27 |
|
$-1.11 |
|
$-1.06 |
|